OPF Offers NEW Home Study CE

NEW: The Role of SERMs in the Prevention and Treatment of Postmenopausal Osteoporosis

In addition to the Continuing Education for Pharmacists home study series in the Ohio Pharmacist journal, the Ohio Pharmacists Foundation provides several additional home study continuing education programs. We are pleased to announce that the following new home study programs, The Role of SERMs in the Prevention and Treatment of Postmenopausal Osteoporosis, Medication Errors in Pharmacy and Management of Bipolar Disorder. These lessons are provided by an educational grant from Eli Lilly and Company. These new programs, as well as the Multiple Sclerosis programs listed below, and many others can be accessed through the OPA online education link below.

• The Role of SERMs in the Prevention and Treatment of Postmenopausal Osteoporosis
  Author: Rosalie Sagraves, Pharm.D., FAPhA, FCCP
  ACPE #129-000-03-050-H01
  Credit: 0.15 CEU
  release date: 6.07.03 expiration date: 6.07.06
  
  This article focuses on postmenopausal osteoporosis and the use of Selective Estrogen Receptor Modulators (SERMs) in its prevention and therapy.
  
  
• Medication Errors in Pharmacy
  Author: Stephen C. Burson, R.Ph.
  ACPE #129-000-03-048-H04
  Credit: 0.15 CEU
  release date: 3.11.03 expiration date: 3.11.06
  
  This program reviews: the basic terminology used to describe medication errors; common causes of medication errors; abbreviations and decimal point placement that should be avoided on prescription orders; measures to help prevent dispensing errors; and important concepts in handling actual medication errors.
  
  
• Management of Bipolar Disorder and Side Effects Caused by Medications
  Author: Nicholas A. Votolato R.Ph.
  ACPE #129-000-03-049-H01
  Credit: 0.15 CEU
  release date: 6.05.03 expiration date: 6.05.06
  
  The goal of this article is to review the heterogeneous nature of bipolar disorder, and provide a conceptual approach to its treatment. The role of newer and older medications used alone and in combination for mood stability will be described. The importance of compliance, long-term monitoring and potential side effects and drug interactions will also be mentioned.
  
  Click on the OPA Education graphic below. Choose the "Catalog Page" tab at the top of the page, then click on the "General CE" folder to get further details on these new courses. Or select any of the other program folders that may interest you.
  

  ---

• Patient Counseling: Multiple Sclerosis: Part 1: The Disease
  Authors: Thomas A. Gossel, R.Ph., Ph.D. and J. Richard Wuest, R.Ph., Pharm.D.
  ACPE #129-000-03-014-H01
  Credit: 0.15 CEU
  release date: 1.15.03 expiration date: 1.15.06
  
  This program reviews the key symptoms, etiology, pathogenesis, treatment objectives and how to counsel patients and/or caregivers on multiple sclerosis. Provided through an educational grant from TEVA Neuroscience.
  
  
• Patient Counseling: Multiple Sclerosis: Part 2: Treatment
  Authors: Thomas A. Gossel, R.Ph., Ph.D. and J. Richard Wuest, R.Ph., Pharm.D.
  ACPE #129-000-03-015-H01
  Credit: 0.15 CEU
  release date: 1.15.03 expiration date: 1.15.06
  
  This program reviews the pharmacology and therapeutic considerations, proposed mechanisms of action, benefits and limitations, adverse effects, major toxicities, and interactions of drugs used in the treatment of multiple sclerosis. Provided through an educational grant from TEVA Neuroscience.

Click on the following link to access these programs:

Choose the "Catalog Page" tab at the top of the page, then click on the "Multiple Sclerosis Series" folder to get further details on the offered courses. Or select any of the other program folders that may interest you.

Note: The Pharmacist Practice Series and "HIPAA and Its Impact on Pharmacy Practice" have been previously published, and no additional credit can be given for completion of the course.